These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17561290)

  • 1. Platelet glycoprotein IIb HPA-3 polymorphism and acute coronary syndromes.
    Lekakis J; Bisti S; Tsougos E; Papathanassiou A; Dagres N; Ikonomidis I; Soteriadou E; Tselepis AD; Goudevenos J; Kremastinos DT
    Int J Cardiol; 2008 Jun; 127(1):46-50. PubMed ID: 17561290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of glycoprotein IIIa A1/A2 gene polymorphism on one-year outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kozieradzka A; Kamiński KA; Pepiński W; Janica J; Korecki J; Skolimowski K; Frankowska E; Kralisz P; Bonda TA; Dobrzycki S; Musiał WJ
    Kardiol Pol; 2006 Dec; 64(12):1350-5; discussion 1356. PubMed ID: 17206538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients.
    Gardemann A; Humme J; Stricker J; Nguyen QD; Katz N; Philipp M; Tillmanns H; Hehrlein FW; Rau M; Haberbosch W
    Thromb Haemost; 1998 Aug; 80(2):214-7. PubMed ID: 9716139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.
    Weiss EJ; Bray PF; Tayback M; Schulman SP; Kickler TS; Becker LC; Weiss JL; Gerstenblith G; Goldschmidt-Clermont PJ
    N Engl J Med; 1996 Apr; 334(17):1090-4. PubMed ID: 8598867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and mortality in patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction. Data from the Malopolska Registry of Acute Coronary Syndromes.
    Dziewierz A; Siudak Z; Dykla D; Rakowski T; Mielecki W; Dubiel JS; Dudek D
    Kardiol Pol; 2009 Feb; 67(2):115-20; discussion 121-2. PubMed ID: 19288373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction.
    Grove EL; Ørntoft TF; Lassen JF; Jensen HK; Kristensen SD
    J Intern Med; 2004 Jun; 255(6):637-44. PubMed ID: 15147527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland.
    Poloński L; Gasior M; Gierlotka M; Kalarus Z; Cieśliński A; Dubiel JS; Gil RJ; Ruzyłło W; Trusz-Gluza M; Zembala M; Opolski G
    Kardiol Pol; 2007 Aug; 65(8):861-72; discussion 873-4. PubMed ID: 17853315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome.
    Tàssies D; Roqué M; Monteagudo J; Martorell T; Sionis A; Arzamendi D; Heras M; Reverter JC
    Thromb Res; 2009 Nov; 124(5):614-8. PubMed ID: 19699511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease.
    Zotz RB; Winkelmann BR; Nauck M; Giers G; Maruhn-Debowski B; März W; Scharf RE
    Thromb Haemost; 1998 Apr; 79(4):731-5. PubMed ID: 9569182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking.
    Lopes NH; Pereira AC; Hueb W; Soares PR; Lanz JR; Gersh BJ; de Oliveira S; Cesar LA; Ramires JF; Krieger JE
    Am J Cardiol; 2004 Jun; 93(12):1469-72. PubMed ID: 15194015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
    Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA
    J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study on value of severity of patient with coronary artery disease evaluated with the thrombosis in myocardial infarction risk score].
    Zheng XY; Meng XK; Li WG; Yang J; Wei G; Fang R
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Apr; 16(4):239-41. PubMed ID: 15068722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes.
    Dabbous OH; Anderson FA; Gore JM; Eagle KA; Fox KA; Mehta RH; Goldberg RJ; Agnelli G; Steg PG;
    Heart; 2008 Feb; 94(2):159-65. PubMed ID: 17575335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-term mortality after percutaneous coronary intervention in patients treated for acute ST-elevation myocardial infarction versus those with unstable and stable angina pectoris.
    Hirsch A; Verouden NJ; Koch KT; Baan J; Henriques JP; Piek JJ; Rohling WJ; van der Schaaf RJ; Tijssen JG; Vis MM; de Winter RJ
    Am J Cardiol; 2009 Aug; 104(3):333-7. PubMed ID: 19616663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with non-ST-elevation myocardial infarction and without chest pain are treated less aggressively and experience higher in-hospital mortality.
    Zdzienicka J; Siudak Z; Zawiślak B; Dziewierz A; Rakowski T; Dubiel J; Dudek D
    Kardiol Pol; 2007 Jul; 65(7):769-75; discussion 776-7. PubMed ID: 17694458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism.
    Durante-Mangoni E; Davies GJ; Ahmed N; Ruggiero G; Tuddenham EG
    Thromb Haemost; 1998 Aug; 80(2):218-9. PubMed ID: 9716140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the glycoprotein Ia collagen receptor subunit A1648G gene polymorphism on coronary artery disease and acute myocardial infarction.
    Kroll H; Gardemann A; Fechter A; Haberbosch W; Santoso S
    Thromb Haemost; 2000 Mar; 83(3):392-6. PubMed ID: 10744142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycoprotein IIb-IIIa inhibitors in the emergency department for patients with non-ST-elevation acute coronary syndromes: principles and practices.
    Lefebvre CW; Hoekstra JW; Bonaca M; Giugliano R
    J Emerg Med; 2009 Feb; 36(2):162-70. PubMed ID: 18353601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human platelet alloantigens (HPA) 1, HPA2, HPA3, HPA4, and HPA5 polymorphisms in sickle cell anemia patients with vaso-occlusive crisis.
    Al-Subaie AM; Fawaz NA; Mahdi N; Al-Absi IK; Al-Ola K; Ameen G; Almawi WY
    Eur J Haematol; 2009 Dec; 83(6):579-85. PubMed ID: 19702628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.